Seven Springs Wealth Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Seven Springs Wealth Group's GILD Position: Q2 2026 in Review
Seven Springs Wealth Group reduced its Gilead Sciences (GILD) stake by 5.8% in Q2 2026, selling an estimated $21.5K and leaving 2,664 shares worth $337K. The position accounts for 0.07% of the portfolio, ranked #68.
Seven Springs Wealth Group first reported a position in GILD in Q4 2019 and has held it in 19 quarters since. The position peaked at $394K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Seven Springs Wealth Group held 2,664 shares of Gilead Sciences worth $337K as of Q2 2026.
- Seven Springs Wealth Group sold 163 Gilead Sciences shares in Q2 2026, an estimated $21.5K.
- Gilead Sciences made up 0.07% of Seven Springs Wealth Group's portfolio in Q2 2026, its #68 holding.
- Seven Springs Wealth Group first reported a position in Gilead Sciences in Q4 2019 and has held it in 19 quarters since.
- Seven Springs Wealth Group's Gilead Sciences position peaked at $394K in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Seven Springs Wealth Group's 13F filing for Q2 2026, filed 4 Aug 2026.